Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortOnce-daily long-acting background insulin.Fast-acting mealtime insulin.
Body systemDiabetes & WeightDiabetes & Weight
Drug classInsulinsInsulins
SupplyPrescription onlyWHO essential medicinePrescription only
Main usesType 1 diabetes (basal), Type 2 diabetesType 1 diabetes (mealtime and pumps), Type 2 diabetes needing mealtime insulin, Diabetic ketoacidosis (IV regimens use soluble insulin)
How it worksReleases slowly from under the skin to keep blood sugar steady all day and night.Works fast to cover the sugar from a meal.
Starts working1–2 hours, no peak10–20 minutes; peak 1–3 hours
Half-lifeDuration about 24 hoursDuration 3–5 hours
Typical adult doseIndividual — commonly started at 10 units (or 0.1–0.2 units/kg) once a day and adjusted to fasting glucose.Individual — given 0–15 minutes before meals, adjusted to carbohydrate intake.
FormsPen injection, Vial, CartridgePen injection, Vial, Pump cartridge
Common side effectsLow blood sugar, Weight gain, Injection-site lumpsLow blood sugar, Injection-site reactions
Serious side effectsSevere hypoglycaemia, Low potassium (rare)Severe hypoglycaemia, Low potassium
Don't take if——
Alcohol——
PregnancyGenerally considered safeInsulin is the mainstay of diabetes treatment in pregnancy.Generally considered safeUsed routinely in pregnancy.
Breastfeeding——
In use since20001999
Brand namesUnited States: Lantus, Toujeo, Basaglar, SemgleeUnited Kingdom: Lantus, Toujeo, AbasaglarIndia: Lantus, Basalog, GlaritusUnited States: NovoLog, FiaspUnited Kingdom: NovoRapid, FiaspIndia: NovoRapid
Legal status——
ATC codeA10AE04A10AB05

Taken together

  • MinorInsulin glargine + Insulin aspart: More risk of low blood sugar

    Both medicines lower blood sugar; combinations are common but hypos become more likely.

Open in the interaction checker